Back to VA Vanguard Capital Management LLC
LGND
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Ligand Pharmaceuticals Incorporated
Yes. Vanguard Capital Management holds 870,950 shares of LGND (Ligand Pharmaceuticals), worth $275.3M, as of its Q2 2026 13F filing. It increased the position by 22,861 shares (+2.7%) from Q1 2026. Vanguard Capital Management has held LGND in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$275.3M
Current Shares
870,950
Total Value Change
+$106M
Total Shares Change
+22,861
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.